110 patents currently held
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.
The next term ends in Oct 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
9
Ending by 2030
Oct 2027
Next term end
54
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2034 · High confidence
Also notable
Ends Jun 2033 · High confidence
Also notable
Ends Mar 2039 · High confidence
Absorbable Implants for Plastic Surgery
US 9,655,715
Cited by 110 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Implants and Methods for Mastopexy
US 11,744,696
Cited by 21 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2033.
Articles of Poly(butylene Succinate) and Copolymers Thereof
US 10,994,057
Cited by 22 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2039. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 2, 2027The maintenance fee for Three-Dimensional Resorbable Implants for Tissue Reinforcement and Hernia Repair (US 10,335,257) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 2 fees due Mar 5 to 26, 2027 · next Mar 5
- 4 fees due Apr 6 to 20, 2027 · next Apr 6
- 2 fees due May 7 to 28, 2027 · next May 7
- 4 fees due Jun 5 to 19, 2027 · next Jun 5
- 4 fees due Jul 7 to 30, 2027 · next Jul 7
- 5 fees due Aug 13 to 25, 2027 · next Aug 13
- 3 fees due Sep 8 to 22, 2027 · next Sep 8
- 3 fees due Oct 2 to 21, 2027 · next Oct 2
- 1 fee due Nov 3, 2027The maintenance fee for Coatings for the Manufacture and Application of Polyhydroxyalkanoate Medical Devices (US 9,326,841) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- Sep 28Assignment recorded on 1 record: Limem, Skander and 3 others to Tepha, Inc. Recorded Sep 28, 2026, executed Sep 22, 2022. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76573, frame 519.
- 2 of the patents on this record were granted since Aug 17, 2026
What they patent
The 5 largest of its 54 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Absorbable Implants for Plastic Surgery | 9 in force | to Dec 2034 |
| Systems and Methods for Mastopexy | 6 in force | to Jun 2033 |
| Methods of Orienting Multifilament Yarn and Monofilaments of POLY-4-Hydroxybutyrate and Copolymers Thereof | 5 in force | to Dec 2035 |
| Medical Devices Containing Compositions of Poly(butylene Succinate) and Copolymers Thereof | 4 in force | to Mar 2042 |
| Methods for 3D Printing of POLY-4-Hydroxybutyrate and Copolymers | 4 in force | to Jul 2040 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,034,270 | Polyhydroxyalkanoate Medical Textiles and Fibers In force · High confidence | In force | High confidence | |
| US 8,753,555 | Medical Devices Containing Oriented Films of POLY-4-Hydroxybutyrate and Copolymers In force · High confidence | In force | High confidence | |
| US 7,618,448 | Polymeric, Degradable Drug-Eluting Stents and Coatings In force · High confidence | In force | High confidence | |
| US 8,961,591 | Polymeric, Degradable Drug-Eluting Stents and Coatings In force · High confidence | In force | High confidence | |
| US 7,641,825 | Method of Making a Polyhydroxyalkanoate Filament In force · High confidence | In force | High confidence | |
| US 8,016,883 | Methods and Devices for Rotator Cuff Repair In force · High confidence | In force | High confidence | |
| US 7,943,683 | Medical Devices Containing Oriented Films of POLY-4-Hydroxybutyrate and Copolymers In force · High confidence | In force | High confidence | |
| US 8,287,909 | Medical Devices Containing Melt-Blown Non-Wovens of POLY-4-Hydroxybutyrate and Copolymers Thereof In force · High confidence | In force | High confidence | |
| US 10,227,718 | Medical Devices Containing Dry Spun Non-Wovens of POLY-4-Hydroxybutyrate and Copolymers In force · High confidence | In force | High confidence | |
| US 8,979,921 | Polymeric, Degradable Drug-Eluting Stents and Coatings In force · High confidence | In force | High confidence |
Also on record, not counted in the 110: 2 patents in force now held by others · 26 patents ended · 18 applications pending · 17 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.